Patents Assigned to Spectra Pharmaceutical Services, Inc.
  • Patent number: 4866049
    Abstract: The present invention relates to ophthalmic compositions and their preparation and use. More specifically, the invention relates to ophthalmic compositions useful in the treatment of surface disorders of the eye caused by abnormal precorneal tear film, and most specifically to the compositions for treatment of so-called dry eye conditions.
    Type: Grant
    Filed: August 10, 1987
    Date of Patent: September 12, 1989
    Assignee: Spectra Pharmaceutical Services, Inc.
    Inventors: A. Edward Maumenee, Richard L. Giovanoni